Latest news
N-able Lowers FY26 Sales Guidance Below $556.210M Estimate - scanx.tradescanx.trade · Mon, 10 Aug 2026 11:52:25 GMTWhy AdaptHealth Stock Plummeted This Week - The Globe and MailThe Globe and Mail · Sun, 09 Aug 2026 17:13:00 GMTANI Pharmaceuticals Inc (ANIP) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 19:01:35 GMTCSV: Profitability and revenue rose in Q2 2026 despite lower funeral volumes and revised guidance - TradingViewTradingView · Thu, 06 Aug 2026 14:38:39 GMTQDEL: Q2 2026 revenue rose 2% year-over-year, but FY 2026 guidance was revised downward amid China headwinds - TradingViewTradingView · Thu, 06 Aug 2026 14:03:04 GMTGoldwin: Q1 profit and sales fell short, leading to a downward revision of first-half guidance - TradingViewTradingView · Thu, 06 Aug 2026 06:54:00 GMTBTMD: Revenue fell 9.5% in Q2 2026, with revised full-year guidance and improving supply outlook - TradingViewTradingView · Wed, 05 Aug 2026 23:10:20 GMTVRRM: Q2 2026 revenue rose 12% to $264M, but 2026 guidance was revised lower amid margin pressures - TradingViewTradingView · Wed, 05 Aug 2026 20:14:26 GMT